TrialBone marrow transplantation2021

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial.

Benoit Tessoulin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.